PHARMAGEN, INC. Liabilities, Fair Value Adjustment
PHARMAGEN, INC. reported Liabilities, Fair Value Adjustment of -$55.18 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:LiabilitiesFairValueAdjustment · last filed 2013-11-14
- PHARMAGEN, INC. liabilities, fair value adjustment for the quarter ending 2013-09-30 was -$410.26K.
- PHARMAGEN, INC. liabilities, fair value adjustment for the quarter ending 2013-06-30 was $474.46K.
- PHARMAGEN, INC. liabilities, fair value adjustment for the quarter ending 2013-03-31 was -$119.38K.
- PHARMAGEN, INC. liabilities, fair value adjustment for the quarter ending 2012-12-31 was -$418.27K.
- PHARMAGEN, INC. liabilities, fair value adjustment for fiscal 2012 was -$251.11K.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2013-09-30 | -$410.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $64.20K derived: sum of 2 quarters · filed 2013-11-14 | -$55.18K 10-Q · filed 2013-11-14 | -$473.45K derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | $474.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $355.08K 10-Q · filed 2013-08-14 | -$63.19K derived: sum of 3 quarters · filed 2013-08-14 | |
| 2013-03-31 | -$119.38K 10-Q · filed 2013-05-15 | -$537.65K derived: sum of 2 quarters · filed 2013-05-15 | ||
| 2012-12-31 | -$418.27K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$251.11K 10-K · filed 2013-04-01 | ||
| 2012-09-30 | $167.17K 10-Q · filed 2012-11-14 |